Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.0%

1 terminated out of 25 trials

Success Rate

95.2%

+8.7% vs benchmark

Late-Stage Pipeline

8%

2 trials in Phase 3/4

Results Transparency

25%

5 of 20 completed with results

Key Signals

5 with results95% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (17)
Early P 1 (1)
P 2 (3)
P 4 (2)

Trial Status

Completed20
Withdrawn4
Terminated1

Trial Success Rate

95.2%

Benchmark: 86.5%

Based on 20 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT06161012Not ApplicableCompletedPrimary

Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear

NCT05713552Not ApplicableCompletedPrimary

Evaluation of ACUVUE® OASYS 1-Day for Astigmatism Contact Lenses With Alternative Lidstock

NCT05530889Not ApplicableWithdrawnPrimary

Evaluating Quality of Life Benefits of ACUVUE® Theravision® With Ketotifen in Subjects With Ocular Allergies

NCT05502289Not ApplicableCompletedPrimary

Clinical Evaluation of Delefilcon A and Verofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of Wear

NCT05427539Not ApplicableCompletedPrimary

Feasibility Evaluation of Daily Disposable Toric Soft Contact Lenses Manufactured With an Alternative Hydration Process

NCT05291936Not ApplicableCompletedPrimary

Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of Wear

NCT00406731Phase 2WithdrawnPrimary

Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure

NCT00712400Not ApplicableCompletedPrimary

Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects

NCT00991900WithdrawnPrimary

Short Term and Day to Day Reproducibility of Reflectometric Measurement of Retinal Oxygen Saturation in Healthy Subjects

NCT00712777Not ApplicableWithdrawnPrimary

Relation Between Intraocular Pressure Lowering Effects of Topical Brimonidine and Alpha 2 Receptor Polymorphism

NCT00708357Early Phase 1TerminatedPrimary

Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?

NCT00706927Not ApplicableCompleted

Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

NCT01663688CompletedPrimary

Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for 3D Measurements of the Eye

NCT00708929Not ApplicableCompleted

Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?

NCT00814047Phase 4Completed

The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery

NCT00712764Not ApplicableCompletedPrimary

Role of Adenosine in the Control of Choroidal Blood Flow During Changes in Ocular Perfusion Pressure.

NCT00712907Not ApplicableCompletedPrimary

Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow

NCT00280462Not ApplicableCompletedPrimary

Choroidal Blood Flow Regulation During Isometric Exercise: Effects of Ca2+-Channel Blockade

NCT00280501Not ApplicableCompleted

Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions

NCT00431730Not ApplicableCompletedPrimary

Is There a Difference in Flicker Induced Vasodilatation Between Smokers and Non-Smokers?

Scroll to load more

Research Network

Activity Timeline